2024-10-17 18:15 | CC:PRN | Profound Medical Corp (2) | 10.69 | News Release200 | Profound Medical to release Q3 2024 results Nov. 7 |
2024-10-16 18:05 | CC:PRN | Profound Medical Corp (2) | 10.55 | News Release200 | Profound Medical appoints Tamberrino as CCO |
2024-09-16 08:00 | CC:PRN | PROFOUND MEDICAL CORP. | 10.56 | News Release200 | Profound Medical's PRO-Talk Live! Event Features the Present and Future of TULSA |
2024-08-08 17:20 | CC:PRN | Profound Medical Corp (2) | 12.89 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2024-08-08 17:14 | CC:PRN | Profound Medical Corp (2) | 12.89 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2024-08-08 16:05 | CC:PRN | PROFOUND MEDICAL CORP. | 13.34 | News Release200 | Profound Medical Announces Second Quarter 2024 Financial Results |
2024-07-18 17:46 | CC:PRN | Profound Medical Corp (2) | 13.55 | News Release200 | Profound Medical to release Q2 results Aug. 8 |
2024-07-11 11:55 | CC:PRN | Profound Medical Corp (2) | 12.20 | News Release200 | Profound notes proposed Category 1 CPT code for Tulsa |
2024-06-14 12:45 | CC:PRN | Profound Medical Corp (2) | 11.07 | SEDAR Preliminary Short Form Prospectus819 | SEDAR Preliminary Short Form Prospectus |
2024-06-14 11:28 | CC:PRN | Profound Medical Corp (2) | | SEDAR Final Short Form Prospectus810 | SEDAR Final Short Form Prospectus |
2024-05-15 16:20 | CC:PRN | Profound Medical Corp (2) | 11.52 | News Release200 | Profound shareholders approve all matters at AGM |
2024-05-14 12:23 | CC:PRN | Profound Medical Corp (2) | 10.45 | News Release200 | Profound receives 510(k) clearance for Tulsa-AI module |
2024-05-09 16:35 | CC:PRN | Profound Medical Corp (2) | 11.64 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2024-05-09 16:28 | CC:PRN | Profound Medical Corp (2) | 11.64 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2024-05-09 16:28 | CC:PRN | Profound Medical Corp (2) | 11.64 | News Release200 | Profound Medical loses $6.19-million (U.S.) in Q1 |
2024-05-06 16:39 | CC:PRN | Profound Medical Corp (2) | 10.04 | News Release200 | Profound talks up Tulsa as prostate treatment |
2024-04-22 16:26 | CC:PRN | Profound Medical Corp (2) | 10.57 | News Release200 | Profound to release Q1 results May 9 |
2024-03-07 16:39 | CC:PRN | Profound Medical Corp (2) | 12.16 | SEDAR Annual Information Form802 | SEDAR Annual Information Form |
2024-03-07 16:39 | CC:PRN | Profound Medical Corp (2) | 12.16 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
2024-03-07 16:39 | CC:PRN | Profound Medical Corp (2) | 12.16 | SEDAR MD & A815 | SEDAR MD & A |
2024-03-07 16:16 | CC:PRN | Profound Medical Corp (2) | 12.16 | News Release200 | Profound Medical loses $33.37-million (U.S.) in 2023 |
2024-02-27 11:49 | CC:PRN | Profound Medical Corp (2) | 11.45 | News Release200 | Profound, Siemens to collaborate to add MR to Tulsa-Pro |
2024-02-15 16:38 | CC:PRN | Profound Medical Corp (2) | 11.28 | News Release200 | Profound Medical to release 2023 results March 7 |
2024-01-16 16:40 | CC:PRN | Profound Medical Corp (2) | 10.78 | News Release200 | Profound Medical arranges $2.93M (U.S.) placement |
2024-01-03 16:26 | CC:PRN | Profound Medical Corp (2) | 10.34 | News Release200 | Profound expects 2023 revenue of $7.1-million |
2023-12-28 09:11 | CC:PRN | Profound Medical Corp (2) | 11.05 | News Release200 | Profound Medical prices $20M (U.S.) public offering |
2023-12-27 16:25 | CC:PRN | Profound Medical Corp (2) | 11.05 | News Release200 | Profound Medical arranges public offering of shares |
2023-11-03 10:28 | CC:PRN | Profound Medical Corp (2) | 12.30 | News Release200 | Profound cheers extension for TULSA code to ASC setting |
2023-11-02 22:27 | CC:PRN | Profound Medical Corp (2) | 12.30 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-11-02 22:24 | CC:PRN | Profound Medical Corp (2) | 12.30 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-11-02 16:39 | CC:PRN | Profound Medical Corp (2) | 12.30 | News Release200 | Profound Medical loses $5.56-million (U.S.) in Q3 |